BSX — Boston Scientific Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual balance sheet for Boston Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1,734	1,925	928	865	414
Net Total Accounts Receivable
Net Total Receivables	1,531	1,778	1,970	2,228	2,558
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	6,694	6,317	5,760	6,514	6,920
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,542	2,687	2,832	3,298	3,743
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	30,777	32,229	32,469	35,136	39,395
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,681	4,274	3,803	4,933	6,399
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	15,451	15,607	14,896	15,854	17,625
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	15,326	16,622	17,573	19,282	21,770
Total Liabilities & Shareholders' Equity	30,777	32,229	32,469	35,136	39,395
Total Common Shares Outstanding
Total Preferred Shares Outstanding